Abstract
Objective: The purpose of this study was to determine the most appropriate dose of oral glutamine to use in a further clinical study in paediatric oncology patients.
Design: This was a phase I, pharmokinetic study.
Setting: The study was carried out at The Yorkshire Regional Centre for Paediatric Oncology and Haematology, St James's University Hospital, Leeds, UK.
Subjects: Thirteen patients undergoing treatment for paediatric malignancy participated in this study. All 13 completed the study.
Interventions: The most appropriate dose was determined by patient acceptability and by plasma glutamine and ammonia levels measured at timed intervals after ingestion of a single glutamine dose.
Results: Doses of 0.35, 0.5 and 0.65 g/kg were well tolerated with no untoward plasma glutamine and ammonia levels. One patient was recruited to a higher dose of 0.75 g/kg, but the plasma glutamine and ammonia levels peaked at 2601 and 155 µmol/l, respectively. The ammonia level was greater than the acceptable upper limit. It was difficult to disperse the glutamine adequately at this dose, resulting in the suspension being found to be unpalatable and therefore no further patients were recruited at this dose.
Conclusion: It was concluded that 0.65 g/kg is a safe dose of glutamine to use in a clinical study in paediatric oncology patients.
Sponsorship: Scientific Hospital Supplies UK Ltd provided the L-glutamine and financial help for the biochemical analysis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Anderson, PM, Schroeder, G & Skubitz, KM (1998). Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer, 83, 1433–1439.
Bode, BP & Souba, WW (1999). Glutamine transport and human hepatocellular transformation. J. Parent Enteral Nutr., 23, S33–S37.
Buchman, AL (1996). Glutamine: is it a conditionally required nutrient for the Human gastrointestinal system?. J. Am. Coll. Nutr., 15, 199–205.
Buchman, AL, Moukarzel, AA, Bhuta, S, Belle, M, Ament, ME, Eckhert, CD, Hollander, D, Gornbein, J, Kopple, JD & Vijayaroghavan, SR (1995). Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. J. Parent Enteral Nutr., 19, 453–460.
Burke, D, Alverdy, JC, Aays, E & Moss, GS (1989). Glutamine supplemented T.P.N. improves gut immune function. Arch. Surg., 124, 1396–1399.
Fox, AD, Kripke, SA, Berman, JR, Gregg Settle, R & Rombeau, JL (1987). Reduction of the severity of enterocolitis by glutamine supplemented enteral diets. Surg. Forum., 38, 43–44.
Fox, AD, De Paula, JA, Kripke, SA, Palacio, CJ, Berman, JM, Gregg Settle, R & Rombeau, JL (1988). Glutamine supplemented elemental diets reduce endotoxaemia in a lethal model of enterocolitis. Surg. Forum, 39, 46–48.
Fox, AD, Kripke, SA, DePaula, J, Berman, JM, Gregg Settle, R & Rombeau, JL (1989). Effect of glutamine supplemented enteral diet on methotrexate Induced enterocolitis. J. Parent Enteral Nutr., 12, 325–331.
Gardiner, KR, Kirk, SJ & Rowlands, BJ (1995). Novel substrates to maintain gut Integrity. Nutr. Res. Rev., 8, 43–64.
Green, A (1988). When and how should we measure plasma ammonia. Ann. Clin. Biochem., 25, 199–209.
Guedon, C, Schmitz, J, Lerebours, E, Metayer, J, Audran, E, Hemet, J & Colin, R (1986). Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastroenterology, 90, 373–378.
Hall, JC, Heel, K & McCauley, R (1996). Glutamine. Br. J. Surg, 83, 305–312.
Jacobs, DO, Evans, DA, O'Dwyer, ST, Smith, RJ & Wilmore, DW (1987). Disparate effects of 5-Fluorouracil on the ileum and colon of enterally fed rats with protection by dietary glutamine. Surg. Forum, 38, 45–46.
Jebb, SA, Marcus, R & Elia, M (1995). A pilot study of oral glutamine supplementation in patients receiving bone marrow transplant. Clin. Nutr., 14, 162–165.
Lacey, JM & Wilmore, DW (1990). Is glutamine a conditionally essential amino acid?. Nutr. Rev., 48, 297–309.
Lind, MJ (1995). Cytotoxic chemotherapy. Medicine, 422–426.
Meijer, AJ, Lamers, WH & Chamuleau, RAFM (1990). Nitrogen metabolism and ornithine cycle functions. Physiol. Rev., 70, 701–749.
Miller, AL (1999). Therapeutic considerations of L-Glutamine: a review of literature. Alter. Med. Rev., 4, 239–248.
Rhoads, M (1999). Glutamine signaling in intestinal cells. J. Parent Enteral Nutr., 23, (Suppl) S38–S40.
Schloerb, PR & Skikne, BS (1999). Oral and parenteral glutamine in bone marrow Transplantation: a randomised, double blind study. J. Parent Enteral Nutr., 23, 117–122.
Skubitz, KM & Anderson, PM (1996). Oral glutamine to prevent chemotherapy induced stomatitis; a pilot study. J. Lab. Clin. Med., 127, 223–228.
Smith, RJ (1997). Glutamine supplemented nutrition. J. Parent Enteral Nutr., 21, 183–184.
Sweetenham, JW, Macbeth, FR, Mead, GM, Williams, JH & Whitehouse, J (1989). Clinical Oncology, 2nd edn Oxford: Blackwell Scientific
Tremel, H, Kienle, B, Weilemann, LS, Stehle, P & Furst, P (1994). Glutamine dipeptide supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology, 107, 1595–1601.
van Acker, BAC, von Meyenfeldt, MF, van der Hulst, RRWJ, Hulsewe, KWE, Wagenmakers, AJM, Deutz, NEP, de Blaauw, I, Dejong, CHC, van Kreel, BK & Soeters, PB (1999). Glutamine: the pivot of our nitrogen economy?. J. Parent Enteral Nutr., 23, S45–S48.
van der Hulst, RRW, van Kreel, BK, von Meyenfeldt, MF, Brummer, R-JM, Arends, J-W, Deutz, NEP & Soeters, PB (1993). Glutamine and the preservation of gut integrity. Lancet, 341, 1363–1365.
van Zaanen, HCT, van der Lelie, H, Trimmer, JG, Frust, P & Sauerwein, HP (1994). Parenteral glutamine dipepdite supplementation does not ameliorate chemotherapy induced toxicity. Cancer, 74, 2879–2884.
Wang, X-D, Jacobs, DO, O'Dwyer, ST, Smith, RJ & Wilmore, DW (1988). Glutamine enriched parenteral nutrition prevents mucosal atrophy following massive small bowel resection. Surg. Forum, 39, 44–46.
Ziegler, TR, Benfell, K, Smith, RJ, Young, LS, Brown, E, Ferrari-Baliviera, E, Lowe, DK & Wilmore, DW (1990). Safety and metabolic effects of L-glutamine administration in humans. J. Parent Enteral Nutr., 14, 137S–146S.
Ziegler, TR, Young, LS, Benfell, K, Scheltinga, M, Hortos, K, Bye, R, Morrow, F, Jacobs, DO, Smith, RJ, Antin, JH & Wilmore, DW (1992). Clinical and metabolic efficacy of glutamine supplemented parenteral nutrition after bone marrow transplantation. Ann. Int. Med., 116, 821–828.
Acknowledgements
We are grateful to SHS International for providing the L-glutamine and financial help for the biochemical analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ward, E., Picton, S., Reid, U. et al. Oral glutamine in paediatric oncology patients: a dose finding study. Eur J Clin Nutr 57, 31–36 (2003). https://doi.org/10.1038/sj.ejcn.1601517
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601517
Keywords
This article is cited by
-
Catabolism of amino acids in livers from cafeteria-fed rats
Molecular and Cellular Biochemistry (2013)
-
Glutamine as indispensable nutrient in oncology: experimental and clinical evidence
European Journal of Nutrition (2010)
-
Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation
Bone Marrow Transplantation (2009)